Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function

Jingyi Hu(Nanjing University of Chinese Medicine), Hai Huang(China Pharmaceutical University), Yuan Che(China Pharmaceutical University), Chujie Ding(China Pharmaceutical University), Lu Zhang(Nanjing University of Chinese Medicine), Yun Wang(Nanjing University of Chinese Medicine), Haiping Hao(China Pharmaceutical University), Hong Shen(Nanjing University of Chinese Medicine), Lijuan Cao(China Pharmaceutical University)
Journal of Ethnopharmacology
September 15, 2020
10.1016/j.jep.2020.113394
Cited by 160

Abstract

Related Papers

Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages
Wai‐Ki Ip, Namiko Hoshi, Dror S. Shouval et al.|Science|2017|1.4k
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
Gilaad G. Kaplan, Siew C. Ng|Gastroenterology|2016|1.2k
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases
Mingming Sun, Wei Wu, Zhanju Liu et al.|Journal of Gastroenterology|2016|1.1k
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Henri Duboc, Sylvie Rajca, Dominique Rainteau et al.|Gut|2012|914
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease
Floris Imhann, Arnau Vich Vila, Marc Jan Bonder et al.|Gut|2016|796